(Q43287499)

English

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer

scientific article published in November 2009

Statements

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer (English)
Jennifer S Temel
Tatjana Kolevska
Craig W Englund
David C Caldwell
Martin J Edelman

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit